May 07, 2019 / 12:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the MediWound Ltd. Strategic Partnership Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Jeremy Feffer, Investor Relations. Jeremy?
Jeremy Feffer - LifeSci Advisors, LLC - MD
Thank you, Nova, and good morning, everyone. Earlier today, MediWound issued a press release announcing that it has entered into an exclusive license and supply agreement with Vericel for commercial rights to NexoBrid in North America. You may access that release on the website under the Investors Relations tab. An investor deck is also available under the Investor tab.
With us today are Steve Wills, Active Chairman of the Board; and Sharon Malka, Chief Executive Officer. Following management's prepared remarks, we will open the call for Q&A.
Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to MediWound's expected future performance, future
MediWound Ltd. - Special Call Transcript
May 07, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers